Omkar Bhatavdekar

Transport-driven engineering of liposomes for delivery of α-particle radiotherapy to solid tumors: effect on inhibition of tumor progression and onset delay of spontaneous metastases

Aprameya Ganesh Prasad, Rajiv Nair, Omkar Bhatavdekar et al. · European Journal of Nuclear Medicine and Molecular Imaging · 2021 · 27 citations

Nanomedicine, Drug Targeting, Nanotherapeutics +13

Growth of Metastatic Triple-Negative Breast Cancer Is Inhibited by Deep Tumor-Penetrating and Slow Tumor-Clearing Chemotherapy: The Case of Tumor-Adhering Liposomes with Interstitial Drug Release

Sally Stras, Alaina Howe, Aprameya Ganesh Prasad et al. · Molecular Pharmaceutics · 2019 · 25 citations

Breast Oncology, Nanotherapeutics, Lipid Nanoparticles +20

Combination of Carriers with Complementary Intratumoral Microdistributions of Delivered <b>α</b>-Particles May Realize the Promise for ²²⁵Ac in Large, Solid Tumors

Alaina Howe, Omkar Bhatavdekar, Dominick Salerno et al. · Journal of Nuclear Medicine · 2021 · 18 citations · Full text

Two diverse carriers are better than one: A case study in α‐particle therapy for prostate specific membrane antigen‐expressing prostate cancers

Dominick Salerno, Alaina Howe, Omkar Bhatavdekar et al. · Bioengineering & Translational Medicine · 2021 · 15 citations · Full text

Nanotherapeutics, Immunotherapeutics, Prostate Specific Membrane +22

FPT, a 2-Aminotetralin, Is a Potent Serotonin 5-HT_1A, 5-HT_1B, and 5-HT_1D Receptor Agonist That Modulates Cortical Electroencephalogram Activity in Adult <i>Fmr1</i> Knockout Mice

Tanishka S. Saraf, Ryan P. McGlynn, Omkar Bhatavdekar et al. · ACS Chemical Neuroscience · 2022 · 13 citations · Full text